Renaissance Capital logo

Ensysce Biosciences (Leisure Acquisition) Priced, Nasdaq: ENSC

Blank check company led by gaming and entertainment veteran Lorne Weil (completed 6/30/2021).

Industry: SPAC

First Day Return: -0.4%

Industry: SPAC

We are a newly organized blank check company. While we may pursue an acquisition opportunity in any industry or sector, we intend to focus on the location-based leisure sector and leisure-related businesses, which complements our management team's sector and operating expertise. The leisure and leisure-related businesses are primarily comprised of companies providing consumer discretionary goods and services. Target business that we are focused on in this sector include, but are not limited to, those in the gaming, travel and recreation subsectors. We believe that the experience and capabilities of our management team will make us an attractive partner to potential target businesses, enhance our ability to complete a successful business combination, and bring value to the business post-business combination. Not only does our management team bring a combination of operating, investing, financial and transactional experience, but also members of our management team have worked closely together in the past at multiple leisure-oriented companies, creating value for stockholders.
more less
IPO Data
IPO File Date 11/03/2017
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 20.0
Deal Size ($mm) $200
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 11/30/2017
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $200
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters New York, NY, United States
Founded 2017
Employees at IPO n/a
Website www.hgvoracapital.com

Ensysce Biosciences (Leisure Acquisition) (ENSC) Performance